Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 5 people enrolled
- Started
- 11 Jun 2025
- Ended
- 21 Sept 2026
- Type of study
- Interventional
- Treatments tested
- EnteroTracker(R) EST
- Record updated
- 5 October 2026
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who cannot take part
- Biopsy-proven high grade dysplastic Barrett s esophagus, active peptic ulcer disease, recent (within 4 weeks) upper GI bleed, and/or history of Zollinger Ellison syndrome or gastric bypass surgery
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy or lactation
- Use of antibiotics with activity against H. pylori within 4 weeks of enrollment
- Inability to swallow pills
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Aged >=18 years
- Diagnosed with H. pylori infection (by endoscopy, stool antigen, or urea breath testing)
- Agreement to adhere to lifestyle considerations throughout study duration
- Ability of participant to provide informed consent
Where in United States
- National Institutes of Health Clinical CenterBethesda, United States
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Helicobacter pylori is a bacterium that infects the lining of the stomach and intestines. It can cause peptic ulcers, cancers, and infections. Current methods of diagnosing H. pylori infections have limitations. Researchers want to test a new method of testing for H. pylori.
Objective:
To compare the esophageal string test (EST) to standard tests for detecting H. pylori infection.
Eligibility:
People aged 18 years or older with persistent H. pylori infection.
Design:
Participants will have 3 or 4 clinic visits over 2 to 4 months.
Screening visit: Participants will have a physical exam. They will provide a stool sample.
Baseline visit: Participants will have blood tests. Then they will have the EST: One end of a string will be taped to the outside of their cheek; the other end will be packed into a capsule. Participants will swallow the capsule, and the string will unwind down their throat into their stomach. The string will be left in for at least 1 hour. Then researchers will gently pull out the string. The fluids soaked into the string will be studied. Some participants will be prescribed antibiotics.
Follow-up visit 1: Participants whose H. pylori infection was cured by the antibiotics may leave the study. Those who are still infected will have an endoscopy: A flexible tube will be inserted down the throat and into the stomach. It will take tissue samples from the stomach lining. These participants will then receive antibiotics again.
Follow-up visit 2: The physical exam, blood test, and stool sample will be repeated.
...
The group in the trial
- EnteroTracker(R) ESTTreatment being tested
Esophageal string test device consists of a gelatin-coated capsule with a collection string wrapped inside.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot Prospective Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
- Record updated
- 5 October 2026